Stroke prevention in clinical practice for primary care physicians

Hong Kong Practitioner

Volumn 26, Issue 2, 2004, Pages 81-92

  Cheung, R T F ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CIMETIDINE; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; FISH OIL; GESTAGEN; INSULIN; METFORMIN; ORAL CONTRACEPTIVE AGENT; POTASSIUM; PROSTAGLANDIN SYNTHASE; PROTHROMBIN; RAMIPRIL; SULFONYLUREA; TICLOPIDINE; UNINDEXED DRUG; WARFARIN;

APLASTIC ANEMIA; ARTICLE; CARDIOVASCULAR DISEASE; CAROTID ARTERY OBSTRUCTION; CAUSE OF DEATH; CIGARETTE SMOKING; CLINICAL PRACTICE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIET THERAPY; DISABILITY; DOSE RESPONSE; DRUG COST; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; FATALITY; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMOBILIZATION; JAUNDICE; LEUKOPENIA; LOW DRUG DOSE; OBESITY; ORAL CONTRACEPTION; PHYSICIAN ATTITUDE; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; RASH; REVASCULARIZATION; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; STROKE; TREATMENT CONTRAINDICATION;

EID: 2342644908     PISSN: 10273948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Wong KS, Huang YN, Gao S, et al. Cerebrovascular disease among Chinese populations - recent epidemiological and neuroimaging studies. HK Med J 2001;7:50-57.
2. Cheung RT. Cerebrovascular disease - advances in management. HK Med J 2001;7:58-66.
3. Cheung RT, Mak W, Chan KH. Circadian variation of stroke onset in Hong Kong Chinese: a hospital-based study. Cerebrovasc Dis 2001;12:1-6.
4. Mak W, Mok KY, Tsoi TH, et al. Cerebral venous thrombosis in Hong Kong. Cerebrovasc Dis 2001;11:282-283.
5. Michel P. Introduction to stroke and its management. Cerebrovasc Dis 2003;15(suppl 2):1-10.
6. Hankey GJ. Risk factor management to prevent stroke. Adv Neurol 2003; 92:179-185.
7. Cheung RT, Yu YL. Primary and secondary prevention of stroke. HK Pract 1998;20:67-77.
8. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913.
9. O'Brien AA, Rajkumar C, Bulpitt CJ. Blood pressure lowering for the primary and secondary prevention of stroke: treatment of hypertension reduces the risk of stroke. J Cardiovasc Risk 1999;6:203-205.
10. Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000;355:865-872.
11. INDANA (Individual Data Analysis of Antihypertensive Intervention Trials) Project Collaborators. Effect of antihypertensive treatment in patients having already suffered a stroke: gathering the evidence. Stroke 1997;28:2557-2562.
12. PROGRESS Collaborative Group. Randomised trials of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041.
13. PATS Collaborating Group. Post-stroke antihypertensive treatment study: a preliminary result. Chin Med J 1995;108:710-717.
14. Heart Outcomes Prevention Evaluation (HOPE) Study investigators. Effects of an angiotensin converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-153.
15. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000;355:1955-1964.
16. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-2997.
17. Pantoni L, Sarti C, Pracucci G, et al. Lipoprotein(a) serum levels and vascular diseases in an older Caucasian population cohort. J Am Geriatr Soc 2001;49:117-125.
18. Rizos E, Mikhailidis DP. Are high density lipoprotein (HDL) and triglyceride levels relevant in stroke prevention? Cardiovasc Res 2001;52: 199-207.
19. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 1995;346:1647-1653.
20. Iso H, Jacobs DR, Wentworth D, et al. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 1989;320:904-910.
21. Di Mascio R, Marchioli R, Tognoni G. Cholesterol reduction and stroke occurrence: an overview of randomised clinical trials. Cerebrovasc Dis 2000; 10:85-92.
22. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
23. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
24. Kernan WN, Inzucchi SE, Viscoli CM, et al. Insulin resistance and risk for stroke. Neurology 2002;59:809-815.
25. Folsom AR, Rasmussen ML, Chambless LE, et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diab Care 1999;22:1077-1083.
26. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991;151:1141-1147.
27. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
28. Palumbo PJ. Glycemic control, mealtime glucose excursions, and diabetic complications in type 2 diabetes mellitus. Mayo Clin Proc 2001;76:609-618.
29. Schulman S. Care of patients receiving long-term anticoagulant therapy. N Engl J Med 2003;349:675-683.
30. Wannamethee SG, Shaper AG, Ebrahim S. History of parental death from stroke or heart trouble and the risk of stroke in middle-aged men. Stroke 1996;27:1492-1498.
31. Chen WH, Ho DS, Ho SL, et al. Prevalence of extracranial carotid and vertebral artery disease in Chinese patients with coronary artery disease. Stroke 1998;29:631-634.
32. Moore WS, Barnett HJM, Beebe HG, et al. Guidelines for carotid endarterectomy - a multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. Stroke 1995;26:188-201.
33. Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention. JAMA 2002;288:1388-1395.
34. Antiplatelet Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ 2002;324:71-86.
35. Hankey GJ, Sudlow CL, Dunbabin DW. Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomised trials. Stroke 2000;31:1779-1784.
36. Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.
37. The Clopidogrel in Unstable angina to prevent Recurrent Events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
38. Adams HP Jr, Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke. A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34: 1056-1083.
39. Broderick JP, Adams HP Jr, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke 1999;30:905-915.